Cohen & Steers’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Cohen & Steers’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-42	Closed	-$3K	–	475
2024 Q2	$3K	Buy	+42	New	+$2.91K	﹤0.01%	413

Other funds holding ITCI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cohen & Steers's ITCI Position: Q3 2024 in Review

Cohen & Steers sold out of Intra-Cellular Therapies Inc. (ITCI) in Q3 2024, closing a stake of 42 shares — an estimated $3K sold.

Cohen & Steers first reported a position in ITCI in Q2 2024 and held it in 1 quarter. The position peaked at $3K in Q2 2024. 355 funds tracked by Wall St. Rank hold ITCI as of Q3 2024.

Cohen & Steers reported no remaining Intra-Cellular Therapies Inc. position as of Q3 2024 after selling out during the quarter.
Cohen & Steers sold 42 Intra-Cellular Therapies Inc. shares in Q3 2024, an estimated $3K.
Cohen & Steers first reported a position in Intra-Cellular Therapies Inc. in Q2 2024 and held it in 1 quarter.
Cohen & Steers's Intra-Cellular Therapies Inc. position peaked at $3K in Q2 2024.
355 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2024.

Based on Cohen & Steers's 13F filing for Q3 2024, filed 14 Nov 2024.